1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 17 AUGUST 2015

World Generic Markets 17 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - NICE Infliximab Pack Shows Way Forward For Introducing Biosimilars
Industry Trend Analysis - Par Will Fight To Retain Megace ES Market Share Despite Falling Sales
Industry Brief - Oncobiologics Secures Biosimilar Development Financing
Industry Brief - Fujifilm Kyowa Kirin Biologics And AstraZeneca Form JV To Develop Anti-VEGF Biosimilar
Industry Brief - Breckenridge Gains US Azelastine Nasal Spray Approval
Industry Brief - Allergan Initiates Treprostinil Patent Challenge
Industry Brief - Aurobindo Gains US Esmolol Approval
Industry Brief - Par Commences Ethacrynate Shipments
Industry Trend Analysis - Synthon's Glatiramer Promises Rich Rewards For Pfizer
Industry Brief - Upsher-Smith Launches Fluoxymesterone In US
Industry Brief - Hikma Challenges Abiraterone Patent
Industry Brief - FDA Reinstates Bioequivalence Requirements For Intellipharmaceutics' Dexmethylphenidate
Industry Brief - STADA And Gedeon Richter Enter Pegfilgrastim Agreement
Industry Trend Analysis - Pfizer/Hospira Growth Prospects Undiminished Despite EC Biosimilar Ruling
Industry Trend Analysis - Indian Protest Underscores Need For Improved EU Pharmaco-Vigilance Oversight
Industry Brief - Alvogen Launches Bortezomib In Bulgaria
Industry Trend Analysis - Irish Expansion Underlines Amneal's Rising Global Profile
Industry Trend Analysis - Divesting Allergan's Generics Business Will Increase Pressure On CNS Franchise
Industry Brief - Sorrento Enters Biosimilars Licensing Agreement With Mabtech
Industry Brief - Hetero Launches Biosimilar Rituximab In India
Industry Trend Analysis - Teva To Maintain Dominance In Global Generics
Industry Brief - Endo Divests Non-Core Business Lines From Litha Healthcare

Table Of Contents

World Generic Markets 17 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.